Which has the lower trailing P/E, BIIB or RMD?

RMD has the lower trailing P/E: BIIB trades at 36.80 and RMD at 20.92. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or RMD?

Over the past five years, RMD grew revenue faster — BIIB at a -3.19% CAGR versus RMD at 12.08%.

Does BIIB or RMD pay a bigger dividend?

RMD pays a dividend (1.13% yield), while BIIB has no payments in the available dividend history.

Is BIIB or RMD more profitable?

RMD runs the higher net margin — BIIB at 8.39% versus RMD at 26.94%.

How have BIIB and RMD total returns compared?

Over the past 10 years, BIIB delivered -4.10% and RMD delivered 13.01% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs ResMed Inc. (RMD)

A side-by-side comparison of Biogen Inc. and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$30.98B

$209.70HealthcareDelayed quote: Aug 10, 2026, 10:00 AM EDT

RMD

ResMed Inc.

$31.55B

$217.51HealthcareDelayed quote: Aug 10, 2026, 10:00 AM EDT

Total return — BIIB vs RMD

growth of $100 · dividends reinvested · last 10y

BIIB -34.2% (-4.1%/yr)RMD +237.0% (+12.9%/yr)RMD compounded faster over this window

Log scale — wide-divergence pair

BIIB RMD

BIIB vs RMD: by the numbers

•RMD is the larger company ($31.55B vs $30.98B market cap).
•RMD trades at the lower trailing earnings multiple (20.92 vs 36.80 P/E), one valuation lens rather than an overall verdict.
•RMD converts more revenue to profit (26.94% vs 8.39% net margin).
•RMD grew revenue faster over the past five years (12.08% vs -3.19% CAGR).
•RMD pays a dividend (1.13% yield), while BIIB has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BIIB	RMD
P/E ratio	36.80	20.92
Forward P/E	16.56	19.05
P/S ratio	3.11	5.95
P/B ratio	1.64	5.07
EV / EBITDA	21.56	14.93
FCF yield	9.60%	5.31%

Profitability

Metric	BIIB	RMD
Gross margin	67.71%	61.06%
Operating margin	12.79%	33.48%
Net margin	8.39%	26.94%
ROE	4.43%	23.13%
ROIC	6.62%	19.05%

Dividends

Metric	BIIB	RMD
Dividend yield	N/A	1.13%

Growth (annualized)

Metric	BIIB	RMD
Revenue CAGR (5Y)	-3.19%	12.08%
EPS CAGR (5Y)	-18.67%	N/A
FCF CAGR (5Y)	-11.63%	36.06%
Total return CAGR (5Y)	-9.36%	-4.21%

Frequently asked

Which has the lower trailing P/E, BIIB or RMD?: RMD has the lower trailing P/E: BIIB trades at 36.80 and RMD at 20.92. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or RMD?: Over the past five years, RMD grew revenue faster — BIIB at a -3.19% CAGR versus RMD at 12.08%.
Does BIIB or RMD pay a bigger dividend?: RMD pays a dividend (1.13% yield), while BIIB has no payments in the available dividend history.
Is BIIB or RMD more profitable?: RMD runs the higher net margin — BIIB at 8.39% versus RMD at 26.94%.
How have BIIB and RMD total returns compared?: Over the past 10 years, BIIB delivered -4.10% and RMD delivered 13.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full RMD analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio ResMed P/E ratio ResMed dividend yield Biogen ROE ResMed ROE Biogen operating margin ResMed operating margin Biogen revenue growth ResMed revenue growth Biogen free cash flow ResMed free cash flow

Biogen & ResMed appear in these rankings

Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.